Sign Up for a Free Account

Thien Thanh Dang-Vu MD PhD FAASM

Professor, Neurologist
Director, Sleep, Cognition & Neuroimaging Laboratory (SCNLab)
Vice-President (Research), Canadian Sleep Society
Center for Studies in Behavioral Neurobiology & PERFORM Center
Department of Health, Kinesiology and Applied Physiology, Concordia University
Associate Director for Clinical Research
Centre de Recherche de l’Institut Universitaire de Gériatrie de Montréal (CRIUGM)
CIUSSS du Centre-Sud-de-l’île-de-Montréal
Montreal, Canada

Thanh Dang-Vu earned his MD in 2004 at the Université de Liège, in Belgium. He then completed his residency in Neurology and a PhD in Biomedical Science at the same university. He did a post-doctoral fellowship in the Department of Neurology at the Massachusetts General Hospital and Harvard Medical School in Boston. He completed a second postdoctoral fellowship at the Center for Advanced Research in Sleep Medicine at the Université de Montreal and Hôpital du Sacré-Coeur de Montréal. He won several research awards, notably from the Sleep Research Society, the European Sleep Research Society, the Belgian Association for Sleep Research and Sleep Medicine, and the Belgian Neurological Society. Dr. Dang-Vu is a Full Professor in the Department of Health, Kinesiology, and Applied Physiology at Concordia University. He is a Concordia University Research Chair in Sleep, Neuroimaging and Cognitive Health, and a FRQS Research Scholar. Dr Dang-Vu is also an attending neurologist and the Associate Director for Clinical Research at the Institut Universitaire de Gériatrie de Montréal (IUGM), the Vice-President (Research) of the Canadian Sleep Society (CSS), a Professeur Associé of Neuroscience at University de Montréal, an Adjunct Professor of Neurology and Neurosurgery at McGill University. He is a member of the College of the Royal Society of Canada.

Contributor Disclosures

Dr. Dang-Vu of Concordia University and CIUSSS du Centre-Sud-de-l’île-de-Montréal received speaker fees from Eisai, consultant fees from Idorsia, and research grants from Jass Pharmaceuticals and Paladin Labs as principal investigator.